Matricelf (MTLF.TA) Stock Price

Matricelf Price

CLOSED
2.44
​
Market closed

Matricelf stock price

Access this data via the Eulerpool API

Matricelf business model & stock analysis

Matricelf Ltd. is a biotechnology company, which engages in research and development of a platform for autologous matrix and cell implants in the field of regenerative medicine and tissue engineering. The firm operates in the field of tissue engineering and regenerative medicine. The Firm develops a platform for autologous 3D printing of neutral human matrix, cells, tissues and organs implants. The implants are manufactured using cellular components originated from the patients themselves, to reduce potential immune response. The firm focuses on the treatment of spinal cord injury (SCI), but is also involved in developing treatment for additional medical conditions, including: Myocardial Infarction (MI), Parkinson’s disease and Age-related Macular Degeneration (AMD). Matricelf Ltd is a spin-out company from Tel Aviv University.

Frequently asked questions about Matricelf

Converted at the current exchange rate, the Matricelf share trades at 0.71 EUR (2.44 ILS).

The revenue cannot currently be calculated for Matricelf.

The profit cannot currently be calculated for Matricelf.

The P/E ratio cannot be calculated for Matricelf at the moment.

The P/S cannot be calculated for Matricelf currently.

The Eulerpool Quality Score for Matricelf is 2/10.

The ISIN of Matricelf is IL0011767915. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Matricelf is MTLF.TA. The ticker symbol is used to trade Matricelf shares on the stock exchange.

Fair ValueTerminal
2.22 ILS
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Israel
Currency
ILS
Initial public offering
Jun 20, 2021
ISIN
IL0011767915
Cusip
M68554100
Market capitalization
71.35 M ILSMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
7.08
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-255.75 %
Last updated Oct 10, 2026, 7:20 AM

Matricelf Peer Group

Matricelf FIGI

MTLF:IT · BBG011F488K3MTRLF:US · BBG012QFG077MTRLF:UV · BBG012QFG0P7

All fundamentals and in-depth analysis of Matricelf

Our stock analysis for Matricelf stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Matricelf. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.